Osaic Holdings’s SELLAS Life Sciences SLS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.73K | Sell |
1,660
-1,000
| -38% | -$1.04K | ﹤0.01% | 6532 |
|
2025
Q1 | $2.87K | Buy |
2,660
+1,000
| +60% | +$1.08K | ﹤0.01% | 6340 |
|
2024
Q4 | $1.73K | Hold |
1,660
| – | – | ﹤0.01% | 6517 |
|
2024
Q3 | $2.08K | Hold |
1,660
| – | – | ﹤0.01% | 6427 |
|
2024
Q2 | $1.98K | Hold |
1,660
| – | – | ﹤0.01% | 6431 |
|
2024
Q1 | $1.68K | Hold |
1,660
| – | – | ﹤0.01% | 6375 |
|
2023
Q4 | $1.76K | Sell |
1,660
-1,660
| -50% | -$1.76K | ﹤0.01% | 6448 |
|
2023
Q3 | $5.44K | Buy |
3,320
+1,660
| +100% | +$2.72K | ﹤0.01% | 6165 |
|
2023
Q2 | $2.61K | Hold |
1,660
| – | – | ﹤0.01% | 6469 |
|
2023
Q1 | $2.37K | Hold |
1,660
| – | – | ﹤0.01% | 6545 |
|
2022
Q4 | $4K | Sell |
1,660
-5
| -0.3% | -$12 | ﹤0.01% | 6384 |
|
2022
Q3 | $3K | Sell |
1,665
-200
| -11% | -$360 | ﹤0.01% | 6595 |
|
2022
Q2 | $4K | Buy |
1,865
+1,000
| +116% | +$2.15K | ﹤0.01% | 6582 |
|
2022
Q1 | $5K | Hold |
865
| – | – | ﹤0.01% | 6423 |
|
2021
Q4 | $5K | Sell |
865
-1,215
| -58% | -$7.02K | ﹤0.01% | 6550 |
|
2021
Q3 | $19K | Buy |
2,080
+500
| +32% | +$4.57K | ﹤0.01% | 5811 |
|
2021
Q2 | $17K | Buy |
1,580
+205
| +15% | +$2.21K | ﹤0.01% | 5747 |
|
2021
Q1 | $11K | Buy |
1,375
+1,065
| +344% | +$8.52K | ﹤0.01% | 5796 |
|
2020
Q4 | $2K | Buy |
310
+150
| +94% | +$968 | ﹤0.01% | 6014 |
|
2020
Q3 | $0 | Hold |
160
| – | – | ﹤0.01% | 6267 |
|
2020
Q2 | $0 | Hold |
160
| – | – | ﹤0.01% | 6178 |
|
2020
Q1 | $0 | Buy |
+160
| New | – | ﹤0.01% | 6059 |
|